Theraflu Tablet, Chewable
NDC Package 0067-0111-01
Package Information
Theraflu (acetaminophen, dextromethorphan hbr) tablets is ▪do not use more than directed▪do not take more than 10 chewable tablets in 24 hours unless directed by a doctor. This formulation utilizes a tablet, chewable delivery system. Marketed by Haleon Us Holdings Llc, this product is identified by NDC 0067-0111 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 2685209 - acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG Chewable Tablet
- RxCUI: 2685209 - APAP 325 MG / dextromethorphan hydrobromide 10 MG Chewable Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0067 - Haleon Us Holdings Llc
- 0067-0111 - Theraflu
- 0067-0111-01 - 20 TABLET, CHEWABLE in 1 BOTTLE
- 0067-0111 - Theraflu
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0067-0111). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0067-0111-01 identifies a specific commercial package of 20 tablet, chewable in 1 bottle of Theraflu Severe Cold Relief Soft Chews, a human over the counter drug labeled by Haleon Us Holdings Llc. This tablet, chewable is formulated for oral use and contains acetaminophen; dextromethorphan hydrobromide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Haleon Us Holdings Llc on June 19, 2024. The current certification is valid through December 31, 2026.
How is this Haleon Us Holdings Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00067011101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.